nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—Gangrene—Hydroxyurea—head and neck cancer	0.0389	0.0437	CcSEcCtD
Felbamate—Leukaemia—Hydroxyurea—head and neck cancer	0.0316	0.0354	CcSEcCtD
Felbamate—Inappropriate antidiuretic hormone secretion—Vinblastine—head and neck cancer	0.016	0.018	CcSEcCtD
Felbamate—Acute leukaemia—Docetaxel—head and neck cancer	0.0155	0.0174	CcSEcCtD
Felbamate—Cerebrovascular disorder—Fluorouracil—head and neck cancer	0.0137	0.0154	CcSEcCtD
Felbamate—Hypomagnesaemia—Hydroxyurea—head and neck cancer	0.0134	0.015	CcSEcCtD
Felbamate—Ileus—Vinblastine—head and neck cancer	0.0132	0.0148	CcSEcCtD
Felbamate—Nystagmus—Vinblastine—head and neck cancer	0.013	0.0147	CcSEcCtD
Felbamate—Enteritis—Docetaxel—head and neck cancer	0.0129	0.0145	CcSEcCtD
Felbamate—Disseminated intravascular coagulation—Docetaxel—head and neck cancer	0.0124	0.0139	CcSEcCtD
Felbamate—Sudden death—Fluorouracil—head and neck cancer	0.012	0.0134	CcSEcCtD
Felbamate—Bullous eruption—Docetaxel—head and neck cancer	0.0112	0.0125	CcSEcCtD
Felbamate—Rectal haemorrhage—Vinblastine—head and neck cancer	0.0103	0.0116	CcSEcCtD
Felbamate—Encephalopathy—Fluorouracil—head and neck cancer	0.00953	0.0107	CcSEcCtD
Felbamate—Nystagmus—Fluorouracil—head and neck cancer	0.00856	0.00962	CcSEcCtD
Felbamate—Neoplasm—Vinblastine—head and neck cancer	0.00843	0.00947	CcSEcCtD
Felbamate—Necrosis—Fluorouracil—head and neck cancer	0.00779	0.00876	CcSEcCtD
Felbamate—Neoplasm—Hydroxyurea—head and neck cancer	0.00768	0.00863	CcSEcCtD
Felbamate—Hepatic failure—Hydroxyurea—head and neck cancer	0.00687	0.00771	CcSEcCtD
Felbamate—Supraventricular tachycardia—Docetaxel—head and neck cancer	0.00674	0.00757	CcSEcCtD
Felbamate—Renal failure acute—Hydroxyurea—head and neck cancer	0.00668	0.00751	CcSEcCtD
Felbamate—Leukocytosis—Fluorouracil—head and neck cancer	0.00651	0.00731	CcSEcCtD
Felbamate—Intestinal obstruction—Docetaxel—head and neck cancer	0.00648	0.00728	CcSEcCtD
Felbamate—Dysarthria—Fluorouracil—head and neck cancer	0.00647	0.00727	CcSEcCtD
Felbamate—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00646	0.00725	CcSEcCtD
Felbamate—Ileus—Docetaxel—head and neck cancer	0.00624	0.00701	CcSEcCtD
Felbamate—Face oedema—Hydroxyurea—head and neck cancer	0.00596	0.00669	CcSEcCtD
Felbamate—Pleural effusion—Docetaxel—head and neck cancer	0.00577	0.00648	CcSEcCtD
Felbamate—GRIN2B—ErbB4 signaling events—YAP1—head and neck cancer	0.00575	0.0523	CbGpPWpGaD
Felbamate—Otitis media—Docetaxel—head and neck cancer	0.00567	0.00637	CcSEcCtD
Felbamate—Necrosis—Docetaxel—head and neck cancer	0.00563	0.00632	CcSEcCtD
Felbamate—Coma—Fluorouracil—head and neck cancer	0.00559	0.00628	CcSEcCtD
Felbamate—Oesophagitis—Fluorouracil—head and neck cancer	0.00559	0.00628	CcSEcCtD
Felbamate—Pancytopenia—Vinblastine—head and neck cancer	0.00555	0.00624	CcSEcCtD
Felbamate—Rigors—Docetaxel—head and neck cancer	0.00541	0.00608	CcSEcCtD
Felbamate—Sepsis—Fluorouracil—head and neck cancer	0.00531	0.00596	CcSEcCtD
Felbamate—Euphoric mood—Fluorouracil—head and neck cancer	0.00526	0.0059	CcSEcCtD
Felbamate—Pancreatitis—Hydroxyurea—head and neck cancer	0.00523	0.00587	CcSEcCtD
Felbamate—Depression—Vinblastine—head and neck cancer	0.0052	0.00584	CcSEcCtD
Felbamate—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00513	0.00576	CcSEcCtD
Felbamate—Pancytopenia—Hydroxyurea—head and neck cancer	0.00506	0.00569	CcSEcCtD
Felbamate—Dysuria—Hydroxyurea—head and neck cancer	0.00499	0.0056	CcSEcCtD
Felbamate—Agranulocytosis—Vinblastine—head and neck cancer	0.00487	0.00547	CcSEcCtD
Felbamate—Weight increased—Hydroxyurea—head and neck cancer	0.00485	0.00545	CcSEcCtD
Felbamate—Drug interaction—Docetaxel—head and neck cancer	0.00476	0.00535	CcSEcCtD
Felbamate—Haemoglobin—Vinblastine—head and neck cancer	0.0047	0.00528	CcSEcCtD
Felbamate—Haemorrhage—Vinblastine—head and neck cancer	0.00468	0.00526	CcSEcCtD
Felbamate—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00465	0.00522	CcSEcCtD
Felbamate—Pharyngitis—Vinblastine—head and neck cancer	0.00465	0.00522	CcSEcCtD
Felbamate—Hearing impaired—Docetaxel—head and neck cancer	0.00464	0.00521	CcSEcCtD
Felbamate—Cardiac failure—Fluorouracil—head and neck cancer	0.00455	0.00511	CcSEcCtD
Felbamate—Respiratory failure—Docetaxel—head and neck cancer	0.0045	0.00505	CcSEcCtD
Felbamate—Osteoarthritis—Fluorouracil—head and neck cancer	0.00444	0.00499	CcSEcCtD
Felbamate—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00442	0.00496	CcSEcCtD
Felbamate—Haemoglobin—Hydroxyurea—head and neck cancer	0.00429	0.00482	CcSEcCtD
Felbamate—Influenza like illness—Docetaxel—head and neck cancer	0.00429	0.00482	CcSEcCtD
Felbamate—Haemorrhage—Hydroxyurea—head and neck cancer	0.00427	0.00479	CcSEcCtD
Felbamate—Hallucination—Hydroxyurea—head and neck cancer	0.00425	0.00477	CcSEcCtD
Felbamate—Cardiac arrest—Fluorouracil—head and neck cancer	0.00422	0.00474	CcSEcCtD
Felbamate—Ataxia—Fluorouracil—head and neck cancer	0.00418	0.00469	CcSEcCtD
Felbamate—Alopecia—Vinblastine—head and neck cancer	0.00414	0.00465	CcSEcCtD
Felbamate—Oesophagitis—Docetaxel—head and neck cancer	0.00403	0.00453	CcSEcCtD
Felbamate—Neoplasm—Docetaxel—head and neck cancer	0.00399	0.00448	CcSEcCtD
Felbamate—Muscular weakness—Fluorouracil—head and neck cancer	0.00392	0.0044	CcSEcCtD
Felbamate—Dysphagia—Fluorouracil—head and neck cancer	0.00384	0.00431	CcSEcCtD
Felbamate—Sepsis—Docetaxel—head and neck cancer	0.00383	0.0043	CcSEcCtD
Felbamate—Chills—Hydroxyurea—head and neck cancer	0.00383	0.0043	CcSEcCtD
Felbamate—Eosinophilia—Fluorouracil—head and neck cancer	0.0038	0.00427	CcSEcCtD
Felbamate—Ill-defined disorder—Vinblastine—head and neck cancer	0.00378	0.00425	CcSEcCtD
Felbamate—Alopecia—Hydroxyurea—head and neck cancer	0.00377	0.00424	CcSEcCtD
Felbamate—Anaemia—Vinblastine—head and neck cancer	0.00377	0.00423	CcSEcCtD
Felbamate—Thrombophlebitis—Docetaxel—head and neck cancer	0.0037	0.00416	CcSEcCtD
Felbamate—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00369	0.00414	CcSEcCtD
Felbamate—Malaise—Vinblastine—head and neck cancer	0.00367	0.00413	CcSEcCtD
Felbamate—Leukopenia—Vinblastine—head and neck cancer	0.00365	0.0041	CcSEcCtD
Felbamate—Pancytopenia—Fluorouracil—head and neck cancer	0.00365	0.00409	CcSEcCtD
Felbamate—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00357	0.00401	CcSEcCtD
Felbamate—Hepatic failure—Docetaxel—head and neck cancer	0.00357	0.00401	CcSEcCtD
Felbamate—Hypertension—Vinblastine—head and neck cancer	0.00352	0.00395	CcSEcCtD
Felbamate—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.0035	0.00394	CcSEcCtD
Felbamate—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00345	0.00387	CcSEcCtD
Felbamate—Pneumonia—Fluorouracil—head and neck cancer	0.00344	0.00387	CcSEcCtD
Felbamate—Anaemia—Hydroxyurea—head and neck cancer	0.00343	0.00386	CcSEcCtD
Felbamate—Discomfort—Vinblastine—head and neck cancer	0.00343	0.00385	CcSEcCtD
Felbamate—Atrial fibrillation—Docetaxel—head and neck cancer	0.00338	0.0038	CcSEcCtD
Felbamate—Renal impairment—Docetaxel—head and neck cancer	0.00337	0.00378	CcSEcCtD
Felbamate—Dermatitis bullous—Docetaxel—head and neck cancer	0.00335	0.00377	CcSEcCtD
Felbamate—Malaise—Hydroxyurea—head and neck cancer	0.00335	0.00376	CcSEcCtD
Felbamate—Urinary tract infection—Fluorouracil—head and neck cancer	0.00333	0.00374	CcSEcCtD
Felbamate—Conjunctivitis—Fluorouracil—head and neck cancer	0.00333	0.00374	CcSEcCtD
Felbamate—Leukopenia—Hydroxyurea—head and neck cancer	0.00333	0.00374	CcSEcCtD
Felbamate—Cardiac failure—Docetaxel—head and neck cancer	0.00328	0.00369	CcSEcCtD
Felbamate—Thrombocytopenia—Vinblastine—head and neck cancer	0.00326	0.00366	CcSEcCtD
Felbamate—Epistaxis—Fluorouracil—head and neck cancer	0.00323	0.00363	CcSEcCtD
Felbamate—Hyponatraemia—Docetaxel—head and neck cancer	0.00322	0.00361	CcSEcCtD
Felbamate—Sinusitis—Fluorouracil—head and neck cancer	0.00321	0.00361	CcSEcCtD
Felbamate—Agranulocytosis—Fluorouracil—head and neck cancer	0.00319	0.00359	CcSEcCtD
Felbamate—Anorexia—Vinblastine—head and neck cancer	0.00317	0.00356	CcSEcCtD
Felbamate—Migraine—Docetaxel—head and neck cancer	0.00315	0.00354	CcSEcCtD
Felbamate—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.00314	0.0286	CbGpPWpGaD
Felbamate—Discomfort—Hydroxyurea—head and neck cancer	0.00313	0.00351	CcSEcCtD
Felbamate—Haemoglobin—Fluorouracil—head and neck cancer	0.00309	0.00347	CcSEcCtD
Felbamate—Rhinitis—Fluorouracil—head and neck cancer	0.00308	0.00346	CcSEcCtD
Felbamate—Haemorrhage—Fluorouracil—head and neck cancer	0.00307	0.00345	CcSEcCtD
Felbamate—Pharyngitis—Fluorouracil—head and neck cancer	0.00305	0.00343	CcSEcCtD
Felbamate—Oedema—Hydroxyurea—head and neck cancer	0.00303	0.00341	CcSEcCtD
Felbamate—Ataxia—Docetaxel—head and neck cancer	0.00301	0.00339	CcSEcCtD
Felbamate—Infection—Hydroxyurea—head and neck cancer	0.00301	0.00338	CcSEcCtD
Felbamate—Paraesthesia—Vinblastine—head and neck cancer	0.00299	0.00335	CcSEcCtD
Felbamate—Dehydration—Docetaxel—head and neck cancer	0.00298	0.00335	CcSEcCtD
Felbamate—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00297	0.00334	CcSEcCtD
Felbamate—Anorexia—Hydroxyurea—head and neck cancer	0.00289	0.00325	CcSEcCtD
Felbamate—Decreased appetite—Vinblastine—head and neck cancer	0.00289	0.00325	CcSEcCtD
Felbamate—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00289	0.00324	CcSEcCtD
Felbamate—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00289	0.00324	CcSEcCtD
Felbamate—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00286	0.0261	CbGpPWpGaD
Felbamate—Pain—Vinblastine—head and neck cancer	0.00284	0.00319	CcSEcCtD
Felbamate—Constipation—Vinblastine—head and neck cancer	0.00284	0.00319	CcSEcCtD
Felbamate—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00283	0.00318	CcSEcCtD
Felbamate—Dysphagia—Docetaxel—head and neck cancer	0.00277	0.00311	CcSEcCtD
Felbamate—Feeling abnormal—Vinblastine—head and neck cancer	0.00274	0.00308	CcSEcCtD
Felbamate—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00272	0.00305	CcSEcCtD
Felbamate—Alopecia—Fluorouracil—head and neck cancer	0.00271	0.00305	CcSEcCtD
Felbamate—Dyspnoea—Hydroxyurea—head and neck cancer	0.0027	0.00304	CcSEcCtD
Felbamate—Somnolence—Hydroxyurea—head and neck cancer	0.0027	0.00303	CcSEcCtD
Felbamate—Dyspepsia—Hydroxyurea—head and neck cancer	0.00267	0.003	CcSEcCtD
Felbamate—Decreased appetite—Hydroxyurea—head and neck cancer	0.00264	0.00296	CcSEcCtD
Felbamate—Pancytopenia—Docetaxel—head and neck cancer	0.00263	0.00296	CcSEcCtD
Felbamate—Abdominal pain—Vinblastine—head and neck cancer	0.00263	0.00295	CcSEcCtD
Felbamate—Fatigue—Hydroxyurea—head and neck cancer	0.00261	0.00294	CcSEcCtD
Felbamate—Pain—Hydroxyurea—head and neck cancer	0.00259	0.00291	CcSEcCtD
Felbamate—Constipation—Hydroxyurea—head and neck cancer	0.00259	0.00291	CcSEcCtD
Felbamate—Weight increased—Docetaxel—head and neck cancer	0.00252	0.00283	CcSEcCtD
Felbamate—Weight decreased—Docetaxel—head and neck cancer	0.00251	0.00282	CcSEcCtD
Felbamate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.0025	0.0228	CbGpPWpGaD
Felbamate—Feeling abnormal—Hydroxyurea—head and neck cancer	0.0025	0.00281	CcSEcCtD
Felbamate—Pneumonia—Docetaxel—head and neck cancer	0.00248	0.00279	CcSEcCtD
Felbamate—Anaemia—Fluorouracil—head and neck cancer	0.00247	0.00278	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00245	0.00275	CcSEcCtD
Felbamate—Jaundice—Docetaxel—head and neck cancer	0.00241	0.0027	CcSEcCtD
Felbamate—Conjunctivitis—Docetaxel—head and neck cancer	0.0024	0.0027	CcSEcCtD
Felbamate—Body temperature increased—Hydroxyurea—head and neck cancer	0.0024	0.00269	CcSEcCtD
Felbamate—Leukopenia—Fluorouracil—head and neck cancer	0.00239	0.00269	CcSEcCtD
Felbamate—Asthenia—Vinblastine—head and neck cancer	0.00239	0.00268	CcSEcCtD
Felbamate—CYP2E1—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00234	0.0213	CbGpPWpGaD
Felbamate—Epistaxis—Docetaxel—head and neck cancer	0.00233	0.00262	CcSEcCtD
Felbamate—Agranulocytosis—Docetaxel—head and neck cancer	0.00231	0.00259	CcSEcCtD
Felbamate—Chest pain—Fluorouracil—head and neck cancer	0.00228	0.00256	CcSEcCtD
Felbamate—Myalgia—Fluorouracil—head and neck cancer	0.00228	0.00256	CcSEcCtD
Felbamate—Diarrhoea—Vinblastine—head and neck cancer	0.00228	0.00256	CcSEcCtD
Felbamate—Discomfort—Fluorouracil—head and neck cancer	0.00225	0.00253	CcSEcCtD
Felbamate—Haemoglobin—Docetaxel—head and neck cancer	0.00223	0.0025	CcSEcCtD
Felbamate—Rhinitis—Docetaxel—head and neck cancer	0.00222	0.0025	CcSEcCtD
Felbamate—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00222	0.0202	CbGpPWpGaD
Felbamate—Hepatitis—Docetaxel—head and neck cancer	0.00222	0.00249	CcSEcCtD
Felbamate—Haemorrhage—Docetaxel—head and neck cancer	0.00222	0.00249	CcSEcCtD
Felbamate—Confusional state—Fluorouracil—head and neck cancer	0.0022	0.00247	CcSEcCtD
Felbamate—Pharyngitis—Docetaxel—head and neck cancer	0.0022	0.00247	CcSEcCtD
Felbamate—Dizziness—Vinblastine—head and neck cancer	0.0022	0.00247	CcSEcCtD
Felbamate—Oedema—Fluorouracil—head and neck cancer	0.00218	0.00245	CcSEcCtD
Felbamate—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00218	0.00245	CcSEcCtD
Felbamate—Asthenia—Hydroxyurea—head and neck cancer	0.00218	0.00244	CcSEcCtD
Felbamate—Infection—Fluorouracil—head and neck cancer	0.00217	0.00244	CcSEcCtD
Felbamate—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00214	0.0024	CcSEcCtD
Felbamate—Visual impairment—Docetaxel—head and neck cancer	0.00214	0.0024	CcSEcCtD
Felbamate—Tachycardia—Fluorouracil—head and neck cancer	0.00213	0.00239	CcSEcCtD
Felbamate—Vomiting—Vinblastine—head and neck cancer	0.00211	0.00237	CcSEcCtD
Felbamate—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—head and neck cancer	0.0021	0.0191	CbGpPWpGaD
Felbamate—Erythema multiforme—Docetaxel—head and neck cancer	0.0021	0.00236	CcSEcCtD
Felbamate—Headache—Vinblastine—head and neck cancer	0.00208	0.00234	CcSEcCtD
Felbamate—Anorexia—Fluorouracil—head and neck cancer	0.00208	0.00234	CcSEcCtD
Felbamate—Diarrhoea—Hydroxyurea—head and neck cancer	0.00207	0.00233	CcSEcCtD
Felbamate—CYP2E1—Vitamin A and Carotenoid Metabolism—RARB—head and neck cancer	0.00207	0.0189	CbGpPWpGaD
Felbamate—Flushing—Docetaxel—head and neck cancer	0.00206	0.00231	CcSEcCtD
Felbamate—Hypotension—Fluorouracil—head and neck cancer	0.00204	0.00229	CcSEcCtD
Felbamate—Dizziness—Hydroxyurea—head and neck cancer	0.00201	0.00225	CcSEcCtD
Felbamate—Chills—Docetaxel—head and neck cancer	0.00199	0.00223	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00199	0.00223	CcSEcCtD
Felbamate—Nausea—Vinblastine—head and neck cancer	0.00198	0.00222	CcSEcCtD
Felbamate—Insomnia—Fluorouracil—head and neck cancer	0.00197	0.00222	CcSEcCtD
Felbamate—Paraesthesia—Fluorouracil—head and neck cancer	0.00196	0.0022	CcSEcCtD
Felbamate—Alopecia—Docetaxel—head and neck cancer	0.00196	0.0022	CcSEcCtD
Felbamate—CYP2E1—Xenobiotics—CYP1A1—head and neck cancer	0.00196	0.0178	CbGpPWpGaD
Felbamate—Dyspnoea—Fluorouracil—head and neck cancer	0.00195	0.00219	CcSEcCtD
Felbamate—Somnolence—Fluorouracil—head and neck cancer	0.00194	0.00218	CcSEcCtD
Felbamate—Vomiting—Hydroxyurea—head and neck cancer	0.00193	0.00217	CcSEcCtD
Felbamate—Dyspepsia—Fluorouracil—head and neck cancer	0.00192	0.00216	CcSEcCtD
Felbamate—Rash—Hydroxyurea—head and neck cancer	0.00191	0.00215	CcSEcCtD
Felbamate—Dermatitis—Hydroxyurea—head and neck cancer	0.00191	0.00215	CcSEcCtD
Felbamate—Headache—Hydroxyurea—head and neck cancer	0.0019	0.00213	CcSEcCtD
Felbamate—Decreased appetite—Fluorouracil—head and neck cancer	0.0019	0.00213	CcSEcCtD
Felbamate—Dysgeusia—Docetaxel—head and neck cancer	0.00189	0.00212	CcSEcCtD
Felbamate—CYP2E1—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00188	0.0171	CbGpPWpGaD
Felbamate—Pain—Fluorouracil—head and neck cancer	0.00187	0.0021	CcSEcCtD
Felbamate—GRIN2A—CREB phosphorylation through the activation of Ras—MAPK1—head and neck cancer	0.00186	0.017	CbGpPWpGaD
Felbamate—GRIN2A—Hypothetical Network for Drug Addiction—MAPK3—head and neck cancer	0.00181	0.0165	CbGpPWpGaD
Felbamate—Nausea—Hydroxyurea—head and neck cancer	0.0018	0.00202	CcSEcCtD
Felbamate—Feeling abnormal—Fluorouracil—head and neck cancer	0.0018	0.00202	CcSEcCtD
Felbamate—Anaemia—Docetaxel—head and neck cancer	0.00178	0.002	CcSEcCtD
Felbamate—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—head and neck cancer	0.00178	0.0163	CbGpPWpGaD
Felbamate—Urticaria—Fluorouracil—head and neck cancer	0.00173	0.00195	CcSEcCtD
Felbamate—Leukopenia—Docetaxel—head and neck cancer	0.00173	0.00194	CcSEcCtD
Felbamate—Body temperature increased—Fluorouracil—head and neck cancer	0.00173	0.00194	CcSEcCtD
Felbamate—GRIN2A—Hypothetical Network for Drug Addiction—MAPK1—head and neck cancer	0.00172	0.0157	CbGpPWpGaD
Felbamate—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.00172	0.0157	CbGpPWpGaD
Felbamate—Palpitations—Docetaxel—head and neck cancer	0.00171	0.00192	CcSEcCtD
Felbamate—Cough—Docetaxel—head and neck cancer	0.00168	0.00189	CcSEcCtD
Felbamate—Hypertension—Docetaxel—head and neck cancer	0.00167	0.00187	CcSEcCtD
Felbamate—GRIN2A—Reelin signaling pathway—PIK3CA—head and neck cancer	0.00166	0.0151	CbGpPWpGaD
Felbamate—Chest pain—Docetaxel—head and neck cancer	0.00164	0.00185	CcSEcCtD
Felbamate—Myalgia—Docetaxel—head and neck cancer	0.00164	0.00185	CcSEcCtD
Felbamate—Arthralgia—Docetaxel—head and neck cancer	0.00164	0.00185	CcSEcCtD
Felbamate—Dry mouth—Docetaxel—head and neck cancer	0.00161	0.00181	CcSEcCtD
Felbamate—Confusional state—Docetaxel—head and neck cancer	0.00159	0.00178	CcSEcCtD
Felbamate—GRIN2B—CREB phosphorylation through the activation of Ras—MAPK1—head and neck cancer	0.00158	0.0144	CbGpPWpGaD
Felbamate—Oedema—Docetaxel—head and neck cancer	0.00158	0.00177	CcSEcCtD
Felbamate—Anaphylactic shock—Docetaxel—head and neck cancer	0.00158	0.00177	CcSEcCtD
Felbamate—Infection—Docetaxel—head and neck cancer	0.00157	0.00176	CcSEcCtD
Felbamate—Pruritus—Fluorouracil—head and neck cancer	0.00154	0.00173	CcSEcCtD
Felbamate—Thrombocytopenia—Docetaxel—head and neck cancer	0.00154	0.00173	CcSEcCtD
Felbamate—GRIN2B—Hypothetical Network for Drug Addiction—MAPK3—head and neck cancer	0.00154	0.014	CbGpPWpGaD
Felbamate—Tachycardia—Docetaxel—head and neck cancer	0.00154	0.00173	CcSEcCtD
Felbamate—GRIN2A—Post NMDA receptor activation events—MAPK1—head and neck cancer	0.00153	0.014	CbGpPWpGaD
Felbamate—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	0.00151	0.0138	CbGpPWpGaD
Felbamate—Anorexia—Docetaxel—head and neck cancer	0.0015	0.00169	CcSEcCtD
Felbamate—GRIN2A—CREB phosphorylation through the activation of Ras—HRAS—head and neck cancer	0.0015	0.0136	CbGpPWpGaD
Felbamate—Diarrhoea—Fluorouracil—head and neck cancer	0.00149	0.00168	CcSEcCtD
Felbamate—Hypotension—Docetaxel—head and neck cancer	0.00147	0.00165	CcSEcCtD
Felbamate—GRIN2B—Hypothetical Network for Drug Addiction—MAPK1—head and neck cancer	0.00146	0.0133	CbGpPWpGaD
Felbamate—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00145	0.0132	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—CASP8—head and neck cancer	0.00145	0.0132	CbGpPWpGaD
Felbamate—Dizziness—Fluorouracil—head and neck cancer	0.00144	0.00162	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00144	0.00161	CcSEcCtD
Felbamate—GRIN2B—ErbB4 signaling events—MAPK3—head and neck cancer	0.00143	0.013	CbGpPWpGaD
Felbamate—Insomnia—Docetaxel—head and neck cancer	0.00142	0.0016	CcSEcCtD
Felbamate—Paraesthesia—Docetaxel—head and neck cancer	0.00141	0.00159	CcSEcCtD
Felbamate—GRIN2B—Reelin signaling pathway—PIK3CA—head and neck cancer	0.00141	0.0129	CbGpPWpGaD
Felbamate—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—head and neck cancer	0.00141	0.0129	CbGpPWpGaD
Felbamate—Dyspnoea—Docetaxel—head and neck cancer	0.0014	0.00158	CcSEcCtD
Felbamate—Somnolence—Docetaxel—head and neck cancer	0.0014	0.00157	CcSEcCtD
Felbamate—Vomiting—Fluorouracil—head and neck cancer	0.00139	0.00156	CcSEcCtD
Felbamate—Dyspepsia—Docetaxel—head and neck cancer	0.00139	0.00156	CcSEcCtD
Felbamate—Rash—Fluorouracil—head and neck cancer	0.00138	0.00155	CcSEcCtD
Felbamate—Dermatitis—Fluorouracil—head and neck cancer	0.00137	0.00154	CcSEcCtD
Felbamate—Decreased appetite—Docetaxel—head and neck cancer	0.00137	0.00154	CcSEcCtD
Felbamate—Headache—Fluorouracil—head and neck cancer	0.00137	0.00154	CcSEcCtD
Felbamate—GRIN2B—ErbB4 signaling events—MAPK1—head and neck cancer	0.00136	0.0124	CbGpPWpGaD
Felbamate—GRIN2A—Reelin signaling pathway—AKT1—head and neck cancer	0.00136	0.0124	CbGpPWpGaD
Felbamate—Fatigue—Docetaxel—head and neck cancer	0.00136	0.00153	CcSEcCtD
Felbamate—Pain—Docetaxel—head and neck cancer	0.00135	0.00151	CcSEcCtD
Felbamate—Constipation—Docetaxel—head and neck cancer	0.00135	0.00151	CcSEcCtD
Felbamate—GRIN2B—Post NMDA receptor activation events—MAPK1—head and neck cancer	0.0013	0.0119	CbGpPWpGaD
Felbamate—Feeling abnormal—Docetaxel—head and neck cancer	0.0013	0.00146	CcSEcCtD
Felbamate—Nausea—Fluorouracil—head and neck cancer	0.0013	0.00146	CcSEcCtD
Felbamate—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00129	0.00145	CcSEcCtD
Felbamate—GRIN2B—CREB phosphorylation through the activation of Ras—HRAS—head and neck cancer	0.00127	0.0116	CbGpPWpGaD
Felbamate—Body temperature increased—Docetaxel—head and neck cancer	0.00125	0.0014	CcSEcCtD
Felbamate—Abdominal pain—Docetaxel—head and neck cancer	0.00125	0.0014	CcSEcCtD
Felbamate—GRIN2A—Post NMDA receptor activation events—HRAS—head and neck cancer	0.00123	0.0112	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—CASP8—head and neck cancer	0.00123	0.0112	CbGpPWpGaD
Felbamate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—head and neck cancer	0.0012	0.0109	CbGpPWpGaD
Felbamate—GRIN2B—ErbB4 signaling events—PIK3CA—head and neck cancer	0.00118	0.0108	CbGpPWpGaD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00116	0.0106	CbGpPWpGaD
Felbamate—GRIN2B—Reelin signaling pathway—AKT1—head and neck cancer	0.00116	0.0105	CbGpPWpGaD
Felbamate—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—head and neck cancer	0.00113	0.0103	CbGpPWpGaD
Felbamate—Asthenia—Docetaxel—head and neck cancer	0.00113	0.00127	CcSEcCtD
Felbamate—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.00112	0.0102	CbGpPWpGaD
Felbamate—Pruritus—Docetaxel—head and neck cancer	0.00111	0.00125	CcSEcCtD
Felbamate—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00109	0.00989	CbGpPWpGaD
Felbamate—Diarrhoea—Docetaxel—head and neck cancer	0.00108	0.00121	CcSEcCtD
Felbamate—GRIN2B—Post NMDA receptor activation events—HRAS—head and neck cancer	0.00105	0.00953	CbGpPWpGaD
Felbamate—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.00104	0.00949	CbGpPWpGaD
Felbamate—Dizziness—Docetaxel—head and neck cancer	0.00104	0.00117	CcSEcCtD
Felbamate—CYP2E1—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00101	0.00916	CbGpPWpGaD
Felbamate—Vomiting—Docetaxel—head and neck cancer	0.001	0.00113	CcSEcCtD
Felbamate—Rash—Docetaxel—head and neck cancer	0.000993	0.00112	CcSEcCtD
Felbamate—Dermatitis—Docetaxel—head and neck cancer	0.000992	0.00111	CcSEcCtD
Felbamate—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000988	0.009	CbGpPWpGaD
Felbamate—Headache—Docetaxel—head and neck cancer	0.000987	0.00111	CcSEcCtD
Felbamate—GRIN2B—Developmental Biology—CEBPA—head and neck cancer	0.000977	0.0089	CbGpPWpGaD
Felbamate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—head and neck cancer	0.000964	0.00878	CbGpPWpGaD
Felbamate—GRIN2B—EPHB-mediated forward signaling—HRAS—head and neck cancer	0.000964	0.00878	CbGpPWpGaD
Felbamate—Nausea—Docetaxel—head and neck cancer	0.000936	0.00105	CcSEcCtD
Felbamate—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000908	0.00827	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—MAPK3—head and neck cancer	0.000878	0.008	CbGpPWpGaD
Felbamate—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000873	0.00795	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—MAPK1—head and neck cancer	0.000836	0.00761	CbGpPWpGaD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000813	0.0074	CbGpPWpGaD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000802	0.00731	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—NAT2—head and neck cancer	0.000747	0.00681	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—MAPK3—head and neck cancer	0.000747	0.0068	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—NAT2—head and neck cancer	0.000737	0.00671	CbGpPWpGaD
Felbamate—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000733	0.00668	CbGpPWpGaD
Felbamate—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000725	0.00661	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—MAPK1—head and neck cancer	0.000711	0.00647	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—TP53—head and neck cancer	0.000702	0.00639	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—VEGFA—head and neck cancer	0.000687	0.00626	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000659	0.006	CbGpPWpGaD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000627	0.00571	CbGpPWpGaD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000619	0.00564	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—TP53—head and neck cancer	0.000597	0.00543	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.000577	0.00525	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000569	0.00518	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.000529	0.00482	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000508	0.00463	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—HRAS—head and neck cancer	0.000496	0.00452	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—STAT3—head and neck cancer	0.000484	0.00441	CbGpPWpGaD
Felbamate—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000466	0.00425	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—MAPK3—head and neck cancer	0.000462	0.00421	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—head and neck cancer	0.00045	0.0041	CbGpPWpGaD
Felbamate—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.000447	0.00407	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—MAPK1—head and neck cancer	0.00044	0.004	CbGpPWpGaD
Felbamate—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000431	0.00393	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000425	0.00387	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000398	0.00362	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000377	0.00343	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000372	0.00339	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—GSTM1—head and neck cancer	0.000369	0.00336	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000364	0.00332	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—head and neck cancer	0.000361	0.00329	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—HRAS—head and neck cancer	0.000353	0.00321	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP1A1—head and neck cancer	0.00035	0.00319	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000347	0.00316	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000345	0.00314	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000342	0.00312	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—MAPK1—head and neck cancer	0.000338	0.00308	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000319	0.00291	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—AKT1—head and neck cancer	0.000312	0.00284	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—NOTCH1—head and neck cancer	0.000311	0.00284	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—UROD—head and neck cancer	0.000308	0.0028	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000306	0.00278	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—MAPK1—head and neck cancer	0.000305	0.00277	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	0.000285	0.00259	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	0.000281	0.00256	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—HRAS—head and neck cancer	0.000271	0.00247	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	0.00027	0.00246	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000266	0.00243	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—MAPK1—head and neck cancer	0.000259	0.00236	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—VEGFA—head and neck cancer	0.000255	0.00233	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—HRAS—head and neck cancer	0.000245	0.00223	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MAPK3—head and neck cancer	0.000242	0.0022	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—UROD—head and neck cancer	0.000237	0.00216	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MAPK1—head and neck cancer	0.00023	0.00209	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—EGFR—head and neck cancer	0.00023	0.00209	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—HRAS—head and neck cancer	0.000208	0.00189	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—HRAS—head and neck cancer	0.000184	0.00168	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000184	0.00168	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—VEGFA—head and neck cancer	0.000182	0.00166	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—STAT3—head and neck cancer	0.00018	0.00164	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MAPK3—head and neck cancer	0.000172	0.00157	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000171	0.00156	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000169	0.00154	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MAPK1—head and neck cancer	0.000164	0.00149	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—EGFR—head and neck cancer	0.000164	0.00149	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000162	0.00148	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00016	0.00146	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—UROD—head and neck cancer	0.000143	0.0013	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—HRAS—head and neck cancer	0.000132	0.0012	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—NAT2—head and neck cancer	0.000128	0.00116	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—AKT1—head and neck cancer	0.000116	0.00106	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—DPYD—head and neck cancer	0.000112	0.00102	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—YAP1—head and neck cancer	0.000106	0.000969	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000105	0.000954	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000104	0.000944	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—NAT2—head and neck cancer	9.86e-05	0.000898	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—DPYD—head and neck cancer	8.65e-05	0.000788	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—YAP1—head and neck cancer	8.21e-05	0.000747	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—TYMS—head and neck cancer	6.39e-05	0.000582	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GSTM1—head and neck cancer	6.31e-05	0.000575	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.17e-05	0.000562	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GPX1—head and neck cancer	6.05e-05	0.000551	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP1A1—head and neck cancer	5.98e-05	0.000545	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—NAT2—head and neck cancer	5.93e-05	0.00054	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.38e-05	0.00049	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—DPYD—head and neck cancer	5.2e-05	0.000474	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—YAP1—head and neck cancer	4.93e-05	0.000449	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—TYMS—head and neck cancer	4.93e-05	0.000449	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GSTM1—head and neck cancer	4.87e-05	0.000444	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GPX1—head and neck cancer	4.66e-05	0.000425	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP1A1—head and neck cancer	4.62e-05	0.000421	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.79e-05	0.000346	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTGS2—head and neck cancer	3.56e-05	0.000324	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PTEN—head and neck cancer	3.1e-05	0.000283	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—TYMS—head and neck cancer	2.96e-05	0.00027	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.93e-05	0.000267	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GPX1—head and neck cancer	2.8e-05	0.000255	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP1A1—head and neck cancer	2.78e-05	0.000253	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTGS2—head and neck cancer	2.75e-05	0.00025	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PTEN—head and neck cancer	2.39e-05	0.000218	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—PIK3CA—head and neck cancer	2.19e-05	0.000199	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—AKT1—head and neck cancer	1.79e-05	0.000163	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—PIK3CA—head and neck cancer	1.69e-05	0.000154	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.65e-05	0.00015	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PTEN—head and neck cancer	1.44e-05	0.000131	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—AKT1—head and neck cancer	1.38e-05	0.000126	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.02e-05	9.25e-05	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—AKT1—head and neck cancer	8.3e-06	7.56e-05	CbGpPWpGaD
